Activator protein 1 transcription factor (c-Fos/c-Jun heterodimer) (AP-1 (c-Fos/c-Jun))

The **c-Fos/c-Jun heterodimer**, also known as **activator protein 1 (AP-1)**, is a transcription factor complex formed by the dimerization of the c-Fos and c-Jun proteins[1][2][4][5]. Both proteins are part of the basic-leucine zipper (bZIP) transcription factor family, and together they regulate gene expression by binding to AP-1 DNA response elements, most commonly the consensus motif 5'-TGAGTCA-3'[2][3]. The heterodimer regulates a wide array of genes associated with cell proliferation, differentiation, apoptosis, and response to stress and inflammatory signals[1][4][5]. AP-1 activity is tightly regulated by extracellular stimuli, including growth factors, cytokines, and cellular stresses, with major roles in cancer, inflammation, and tissue remodeling[4][5]. While the c-Fos/c-Jun complex is a significant therapeutic target in oncology and inflammatory disease research, direct inhibitors are not approved for clinical use. Attempts to modulate its activity center on upstream kinase pathways or experimental small molecules that disrupt dimerization or DNA binding. Such approaches are limited by the broad physiological roles and safety risks inherent in targeting a key regulator of cellular transcriptional programs[5].

Other names

AP-1Activator protein 1Proto-oncogene protein c-FosProto-oncogene protein c-JunFos/Jun complex

Inhibition of dimerization (experimental); Inhibition of DNA binding to AP-1 sites (experimental); Modulation of upstream signaling pathways (e.g., JNK or ERK kinases); Epigenetic modulation affecting Fos/Jun target recognition (research context)[3]